Fortress Biotech, Inc. (FBIOP) vs Organigram Global Inc. (OGI)

A side-by-side comparison of Fortress Biotech, Inc. and Organigram Global Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FBIOP vs OGI

growth of $100 · dividends reinvested · last 7y
FBIOP +67.4% (+7.6%/yr)OGI -97.0% (-39.4%/yr)FBIOP compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120232025$167$3
FBIOP OGI

FBIOP vs OGI: by the numbers

  • •FBIOP is the larger company ($140M vs $134M market cap).
  • •OGI trades at the lower trailing earnings multiple (2.14 vs 6.62 P/E), one valuation lens rather than an overall verdict.
  • •FBIOP converts more revenue to profit (163.32% vs 27.54% net margin).
  • •OGI grew revenue faster over the past five years (29.78% vs 5.39% CAGR).

Metrics side by side

Valuation

MetricFBIOPOGI
P/E ratio6.622.14
Forward P/E6.96N/A
P/S ratio2.040.61
P/B ratio0.850.39
EV / EBITDAN/A10.50
FCF yield90.06%N/A

Profitability

MetricFBIOPOGI
Gross margin62.53%3.67%
Operating margin-111.00%-34.07%
Net margin163.32%27.54%
ROE68.12%15.55%
ROIC-10.85%-0.98%

Growth (annualized)

MetricFBIOPOGI
Revenue CAGR (5Y)5.39%29.78%
Total return CAGR (5Y)0.05%-36.62%

Frequently asked

Which has the lower trailing P/E, FBIOP or OGI?
OGI has the lower trailing P/E: FBIOP trades at 6.62 and OGI at 2.14. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, FBIOP or OGI?
Over the past five years, OGI grew revenue faster — FBIOP at a 5.39% CAGR versus OGI at 29.78%.
Is FBIOP or OGI more profitable?
FBIOP runs the higher net margin — FBIOP at 163.32% versus OGI at 27.54%.
How have FBIOP and OGI total returns compared?
Over the past 5 years, FBIOP delivered 0.05% and OGI delivered -36.62% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.